Literature DB >> 6715172

[Xeroderma pigmentosum: prevention of tumors with etretinate].

E Pichler, P Fritsch.   

Abstract

A 46-year-old woman with xeroderma pigmentosum has had more than one hundred skin tumours in her life, in recent years largely keratoacanthomas. Two and a half years ago, a low-dose prophylactic treatment with etretinate (25 mg/day) was initiated. Since then, no further skin tumours have arisen except for several very small, rapidly resolving keratoacanthomas.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715172

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  1 in total

1.  Xeroderma pigmentosum variant: 5 years of tumour suppression by etretinate.

Authors:  J Berth-Jones; J Cole; A R Lehmann; C F Arlett; R A Graham-Brown
Journal:  J R Soc Med       Date:  1993-06       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.